ClinicalTrials.Veeva

Menu

Detection and Analysis of MBC With Heterogeneous ER Expression

Fudan University logo

Fudan University

Status

Completed

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05392985
YOUNGBC-20

Details and patient eligibility

About

To investigate the treatment pattern and efficacy of MBC patients with ER heterogeneity using a novel convenient way of 18F-fluoroestradiol positron emission tomography/computed tomography (18F-FES PET/CT).

Enrollment

51 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients received 18F-FES PET/CT in Fudan University Shanghai Cancer Center from 2017-2021.
  • Patients had both FES positive (FES+) and negative (FES-) lesions in FES exam.
  • Patients received further treatment.

Exclusion criteria

  • Incomplete medical records.

Trial design

51 participants in 1 patient group

FES+-
Description:
MBC patients with both FES positive(+) and negative(-) lesions.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems